Found: 11
Select item for more details and to access through your institution.
Tumor-intrinsic NLRP3-HSP70-TLR4 axis drives premetastatic niche development and hyperprogression during anti–PD-1 immunotherapy.
- Published in:
- Science Translational Medicine, 2022, v. 14, n. 672, p. 1, doi. 10.1126/scitranslmed.abq7019
- By:
- Publication type:
- Article
Overcoming Immunotherapy Resistance by Targeting the Tumor-Intrinsic NLRP3-HSP70 Signaling Axis.
- Published in:
- Cancers, 2021, v. 13, n. 19, p. 4753, doi. 10.3390/cancers13194753
- By:
- Publication type:
- Article
Novel bone morphogenetic protein signaling through Smad2 and Smad3 to regulate cancer progression and development.
- Published in:
- FASEB Journal, 2014, v. 28, n. 3, p. 1248, doi. 10.1096/fj.13-239178
- By:
- Publication type:
- Article
Factor XIIIA-expressing inflammatory monocytes promote lung squamous cancer through fibrin cross-linking.
- Published in:
- Nature Communications, 2018, v. 9, n. 1, p. 1, doi. 10.1038/s41467-018-04355-w
- By:
- Publication type:
- Article
A lactate-SREBP2 signaling axis drives tolerogenic dendritic cell maturation and promotes cancer progression.
- Published in:
- Science Immunology, 2024, v. 9, n. 95, p. 1, doi. 10.1126/sciimmunol.adi4191
- By:
- Publication type:
- Article
Early carcinogenesis involves the establishment of immune privilege via intrinsic and extrinsic regulation of indoleamine 2,3-dioxygenase-1: translational implications in cancer immunotherapy.
- Published in:
- Frontiers in Immunology, 2014, v. 5, p. 1, doi. 10.3389/fimmu.2014.00438
- By:
- Publication type:
- Article
A tumor-intrinsic PD-L1/NLRP3 inflammasome signaling pathway drives resistance to anti-PD-1 immunotherapy.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Tumor-secreted Pros1 inhibits macrophage M1 polarization to reduce antitumor immune response.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Type III TGF-β receptor downregulation generates an immunotolerant tumor microenvironment.
- Published in:
- Journal of Clinical Investigation, 2013, v. 123, n. 9, p. 3925, doi. 10.1172/JCI65745
- By:
- Publication type:
- Article
MERTK mediated novel site Akt phosphorylation alleviates SAV1 suppression.
- Published in:
- Nature Communications, 2019, v. 10, n. 1, p. N.PAG, doi. 10.1038/s41467-019-09233-7
- By:
- Publication type:
- Article
MERTK Inhibition as a Targeted Novel Cancer Therapy.
- Published in:
- International Journal of Molecular Sciences, 2024, v. 25, n. 14, p. 7660, doi. 10.3390/ijms25147660
- By:
- Publication type:
- Article